Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Insight Molecular Diagnostics Inc. (IMDX)
USD4.72
+0.26 (+5.88%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
15 Cushing 92618
Nashville, TN, US
Nashville, TN, US
CEO
Joshua Riggs
Website
imdxinc.com
IPO
2015-12-30
CIK 1642380 ISIN US68235C2061
Also trades on
London Stock Exchange · 0KCC.L (USD)
NASDAQ Capital Market · IMDX (USD)
NASDAQ Global Market · OCX (USD)
Description
OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.72
+0.26 (+5.88%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
363.2K
Beta
1.77
Float Shares
7.29M
Free Float %
27.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.41% | +4.72% | +70.00% | -8.44% | -35.03% | -32.00% | +84.12% | -4.14% | -93.33% | -93.66% | -96.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
4.72
Low
12.00
+154.1%
Consensus
12.00
+154.1%
Median
12.00
+154.1%
High
12.00
+154.1%
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
12.00
+154.1%
|
| Last Year | 3 |
9.67
+104.8%
|
| All Time | 10 |
21.33
+351.7%
|
Quality scores
Altman Z-Score
-14.14
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+115.6% ★ Q1'26: -98.5% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+64.6% ★ Q1'26: +53.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-689.5% Q1'26: -23,871.9% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-754.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+133.2% Q1'26: +34.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-0.12× Q1'26: -0.17× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
1.50M
est: 1.42M (+5.9%)
|
1.88M
est: 500.0K (+276.2%)
|
4.06M
est: 3.23M (+25.7%)
|
2.59M
713.0K – 5.02M
-19.7% YoY
|
8.17M
1.30M – 11.89M
+215.7% YoY
|
| EBITDA |
-23.12M
est: -1.42M (-1,529.0%)
|
-59.02M
est: -500.0K (-11,703.0%)
|
-28.38M
est: -3.23M (-780.0%)
|
-2.59M
-5.02M – -713.0K
+19.7% YoY
|
-8.17M
-11.89M – -1.30M
-215.7% YoY
|
| EBIT |
-24.80M
est: -1.42M (-1,647.3%)
|
-60.58M
est: -500.0K (-12,015.8%)
|
-30.58M
est: -3.23M (-848.2%)
|
-2.59M
-5.02M – -713.0K
+19.7% YoY
|
-8.17M
-11.89M – -1.30M
-215.7% YoY
|
| Net Income |
-27.78M
est: -16.99M (-63.5%)
|
-60.66M
est: -63.42M (+4.3%)
|
-50.22M
est: -50.22M (+0.0%)
|
-31.49M
-39.88M – -8.13M
+37.3% YoY
|
-26.65M
-29.24M – -24.06M
+15.4% YoY
|
| SGA |
13.29M
est: 19.04M (-30.2%)
|
13.79M
est: 5.21M (+164.5%)
|
16.98M
est: 33.61M (-49.5%)
|
26.97M
7.43M – 52.33M
-19.7% YoY
|
85.15M
13.54M – 123.95M
+215.7% YoY
|
| EPS |
-3.75
est: -1.30 (-188.5%)
|
-4.66
est: -2.74 (-70.1%)
|
-1.65
est: -1.15 (-44.1%)
|
-0.95
-1.31 – -0.27
+17.3% YoY
|
-0.87
-0.96 – -0.79
+8.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-33.34M
OE per share TTM
-1.02
Owner's Yield
-18.94%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
343.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
9
Total invested
964.8K
Insider transactions (90d)
5
Beneficial owners (>5%)
16
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kamen | 12.22M | 15.54% | — | 12.22M | — | 12.22M | HC | Cayman Islands | 2021-01-28 | ↗ |
| 2 | Vida Investments, LLC | 12.22M | 15.54% | — | 12.22M | — | 12.22M | IA | Cayman Islands | 2021-01-28 | ↗ |
| 3 | Pura Vida Master Fund, Ltd. | 7.43M | 6.26% | — | — | — | 7.43M | OO | Cayman Islands | 2023-02-14 | ↗ |
| 4 | AWM Investment Company, Inc. | 7.25M | 6.10% | 7.25M | — | 7.25M | — | — | Delaware, United States | 2023-02-14 | ↗ |
| 5 | Peter Gutfreund | 7.13M | 6.00% | — | 7.13M | — | 7.13M | IN | Delaware, USA | 2022-04-18 | ↗ |
| 6 | Special Situations Fund LLC | 7.13M | 6.00% | — | 7.13M | — | 7.13M | OO | Delaware, USA | 2022-04-18 | ↗ |
| 7 | Pawel Borowiec | 6.60M | 5.50% | — | 6.60M | — | — | IA | Connecticut | 2022-11-25 | ↗ |
| 8 | Vida Master Fund, Ltd. | 5.68M | 7.22% | — | 5.68M | — | 5.68M | OO | Cayman Islands | 2021-01-28 | ↗ |
| 9 | George Karfunkel | 5.12M | 9.50% | 5.12M | — | 5.12M | — | IN | America | 2019-05-22 | ↗ |
| 10 | (1) BlackRock, Inc. | 5.01M | 4.20% | 4.97M | — | 5.01M | — | HC | Delaware | 2022-05-09 | ↗ |
| 11 | (1)Names of reporting persons. BlackRock, Inc. | 4.99M | 5.40% | 4.95M | — | 4.99M | — | HC | Delaware | 2022-02-04 | ↗ |
| 12 | Bio-Rad Laboratories, Inc. | 1.20M | 8.99% | 1.20M | — | 1.20M | — | CO | — | 2024-04-22 | ↗ |
| 13 | PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 | 1.01M | 6.00% | — | 1.01M | — | 1.01M | OO | Arizona | 2024-10-09 | ↗ |
| 14 | W. Smith | 1.01M | 6.00% | — | 1.01M | — | 1.01M | IN | States of America | 2024-10-09 | ↗ |
| 15 | Efrem Kamen | 616.6K | 4.57% | — | — | 13.00 | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 16 | Pura Vida Investments, LLC | 616.6K | 4.57% | — | — | 13.00 | — | IA | Delaware | 2024-11-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
9
-25 vs prev Q
New positions
3
Closed positions
28
Increased
5
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BROADWOOD CAPITAL INC | 11.41M +— (+0.0%) | 85.58M +47.7M (+125.9%) | 35.62% +0.000 pp | 5.03% +2.747 pp | USD2.97 +152.5% | 10 qtrs — |
| 2 | AWM INVESTMENT COMPANY, INC. | 2.81M -8.3K (-0.3%) | 21.11M +11.7M (+125.2%) | 8.79% -0.026 pp | 2.04% +1.160 pp | USD3.00 +150.0% | 6 qtrs — |
| 3 | PURA VIDA INVESTMENTS, LLC | 947.1K +— (+0.0%) | 7.10M +4.0M (+125.9%) | 2.96% +0.000 pp | 26.55% +7.391 pp | USD3.31 +126.6% | 10 qtrs — |
| 4 | VANGUARD GROUP INC | 526.7K +39.9K (+8.2%) | 3.95M +2.3M (+144.4%) | 1.64% +0.125 pp | 0.00% +0.000 pp | USD3.40 +120.6% | 10 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 231.0K +32.5K (+16.4%) | 1.73M +1.1M (+163.1%) | 0.72% +0.102 pp | 0.00% +0.000 pp | USD3.63 +106.6% | 10 qtrs — |
| 6 | BLACKROCK, INC. | 131.4K +43.4K (+49.4%) | 985.2K +693.2K (+237.4%) | 0.41% +0.136 pp | 0.00% +0.000 pp | USD4.40 +70.5% | 6 qtrs — |
| 7 | 683 CAPITAL MANAGEMENT, LLC | 77.2K +77.2K (+100.0%) | 579.0K +579.0K (+100.0%) | 0.24% +0.241 pp | 0.03% +0.025 pp | USD7.50 +0.0% | 1 qtrs NEW |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72.5K +72.5K (+100.0%) | 543.4K +543.4K (+100.0%) | 0.23% +0.226 pp | 0.00% +0.000 pp | USD7.50 +0.0% | 4 qtrs — |
| 9 | MILLENNIUM MANAGEMENT LLC | 61.4K -11.9K (-16.3%) | 460.3K +217.0K (+89.2%) | 0.19% -0.037 pp | 0.00% +0.000 pp | USD3.26 +130.1% | 4 qtrs — |
| 10 | NORTHERN TRUST CORP | 48.9K +16.0K (+48.5%) | 366.4K +257.2K (+235.6%) | 0.15% +0.050 pp | 0.00% +0.000 pp | USD4.47 +67.8% | 7 qtrs — |
| 11 | STATE STREET CORP | 47.8K +5.9K (+14.1%) | 358.2K +219.2K (+157.7%) | 0.15% +0.018 pp | 0.00% +0.000 pp | USD3.74 +100.5% | 10 qtrs — |
| 12 | JANE STREET GROUP, LLC | 42.5K +42.5K (+100.0%) | 318.5K +318.5K (+100.0%) | 0.13% +0.133 pp | 0.00% +0.000 pp | USD7.50 +0.0% | 1 qtrs NEW |
| 13 | FNY INVESTMENT ADVISERS, LLC | 40.6K -12.5K (-23.5%) | 304.0K +128.0K (+72.7%) | 0.13% -0.039 pp | 0.09% +0.029 pp | USD3.10 +141.9% | 7 qtrs — |
| 14 | MORGAN STANLEY | 35.9K -26.3K (-42.3%) | 269.3K +62.8K (+30.4%) | 0.11% -0.082 pp | 0.00% +0.000 pp | USD3.12 +140.4% | 10 qtrs — |
| 15 | QUBE RESEARCH & TECHNOLOGIES LTD | 28.4K +28.4K (+100.0%) | 212.6K +212.6K (+100.0%) | 0.09% +0.089 pp | 0.00% +0.000 pp | USD7.50 +0.0% | 1 qtrs NEW |
| 16 | OMERS ADMINISTRATION CORP | 26.2K +26.2K (+100.0%) | 196.2K +196.2K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.001 pp | USD7.50 +0.0% | 1 qtrs NEW |
| 17 | ADVISOR GROUP HOLDINGS, INC. | 24.1K +12.9K (+115.2%) | 181.0K +151.7K (+517.3%) | 0.08% +0.040 pp | 0.00% +0.000 pp | USD5.54 +35.4% | 10 qtrs — |
| 18 | CITADEL ADVISORS LLC | 15.6K +3.9K (+32.7%) | 117.4K +78.2K (+199.9%) | 0.05% +0.012 pp | 0.00% +0.000 pp | USD4.16 +80.3% | 4 qtrs — |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 13.4K -10.2K (-43.2%) | 100.5K +22.1K (+28.3%) | 0.04% -0.032 pp | 0.00% +0.000 pp | USD3.02 +148.3% | 3 qtrs — |
| 20 | HUDSON BAY CAPITAL MANAGEMENT LP | 13.1K +13.1K (+100.0%) | 98.0K +98.0K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.000 pp | USD7.50 +0.0% | 1 qtrs NEW |
| 21 | PRIVATE ADVISOR GROUP, LLC | 10.4K +— (+0.0%) | 78.1K +43.5K (+125.9%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD3.32 +125.9% | 2 qtrs — |
| 22 | EVERSOURCE WEALTH ADVISORS, LLC | 5.0K +— (+0.0%) | 37.5K +20.9K (+125.9%) | 0.02% +0.000 pp | 0.00% +0.001 pp | USD3.02 +148.3% | 3 qtrs — |
| 23 | UBS GROUP AG | 2.9K +227.0 (+8.4%) | 22.1K +13.0K (+144.8%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD3.29 +128.0% | 10 qtrs — |
| 24 | ORG PARTNERS LLC | 450.00 +— (+0.0%) | 3.4K +1.9K (+125.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.04 +146.7% | 4 qtrs — |
| 25 | BANK OF AMERICA CORP /DE/ | 335.00 -111.0 (-24.9%) | 2.5K +1.0K (+69.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.99 +150.8% | 10 qtrs — |
| 26 | TOWER RESEARCH CAPITAL LLC (TRC) | 250.00 -374.0 (-59.9%) | 1.9K -197.0 (-9.5%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.90 +158.6% | 10 qtrs — |
| 27 | SBI SECURITIES CO., LTD. | 185.00 +— (+0.0%) | 1.4K +774.0 (+126.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.38 +215.1% | 5 qtrs — |
| 28 | JPMORGAN CHASE & CO | 154.00 +— (+0.0%) | 1.2K +644.0 (+126.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.95 +154.2% | 10 qtrs — |
| 29 | BNP PARIBAS ARBITRAGE, SNC | 30.00 +— (+0.0%) | 225.00 +125.0 (+125.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.43 +208.6% | 5 qtrs — |
| 30 | PISCATAQUA SAVINGS BANK | 25.00 +— (+0.0%) | 187.00 +105.0 (+128.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.12 +140.4% | 10 qtrs — |
| 31 | ALBION FINANCIAL GROUP /UT | 7.00 +— (+0.0%) | 53.00 +29.0 (+120.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 +150.0% | 10 qtrs — |
| 32 | CITIGROUP INC | 1.00 +1.0 (+100.0%) | 8.00 +8.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.00 +7.1% | 1 qtrs NEW |
| 33 | GLOBAL RETIREMENT PARTNERS, LLC | 1.00 +— (+0.0%) | 8.00 +5.0 (+166.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 +150.0% | 3 qtrs — |
| 34 | WELLS FARGO & COMPANY/MN | — -3.0 (-100.0%) | — -10.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 219.7K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 1.51M | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 6.3K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 17.2K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.3K | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 2.94M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 6.4K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 3.5K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 1.4K | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 155.94 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
12
Sells
0
Shares acquired
753.0K
Shares disposed
—
Cash buys
12.00
Cash sales
—
Net activity
+753,045
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 250,923 | 3.64 | 913.1K | 12,684,884 | D | ↗ |
| 2026-04-24 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 38,880 | 3.53 | 137.1K | 12,433,961 | D | ↗ |
| 2026-04-23 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 280,381 | 3.50 | 982.0K | 12,395,081 | D | ↗ |
| 2026-04-20 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 0.00 | — | 12,114,700 | I | ↗ |
| 2026-04-17 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 40,114 | 3.57 | 143.3K | 12,074,010 | D | ↗ |
| 2026-04-16 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 102,057 | 3.45 | 351.7K | 12,033,896 | D | ↗ |
| 2026-03-26 | Riggs Josh | Director / Officer | M-Exempt | D | Restricted Stock Units | 47,170 | 0.00 | — | 141,509 | D | ↗ |
| 2026-03-26 | Liu James Yang | Officer | M-Exempt | D | Restricted Stock Units | 6,289 | 0.00 | — | 12,578 | D | ↗ |
| 2026-03-26 | James Andrea S. | Officer | M-Exempt | A | Common Stock | 28,302 | 0.00 | — | 217,358 | D | ↗ |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 521,739 | 5.75 | 3.00M | 11,931,839 | D | ↗ |
| 2025-10-31 | James Andrea S. | Officer | M-Exempt | D | Restricted Stock Units | 50,000 | 0.00 | — | 50,000 | D | ↗ |
| 2025-09-28 | Riggs Josh | Director / Officer | A-Award | A | Option to Purchase Common Stock | 400,000 | 3.33 | 1.33M | 400,000 | D | ↗ |
| 2025-09-28 | Liu James Yang | Officer | A-Award | A | Option to Purchase Common Stock | 18,000 | 3.33 | 59.9K | 18,000 | D | ↗ |
| 2025-09-28 | James Andrea S. | Officer | A-Award | A | Option to Purchase Common Stock | 235,000 | 3.33 | 782.6K | 235,000 | D | ↗ |
| 2025-07-01 | SILVERMAN LOU | Director | A-Award | A | Common Stock, no par value | 35,000 | 0.00 | — | 36,564 | D | ↗ |
| 2025-07-01 | Last Andrew J. | Director | A-Award | A | Common Stock, no par value | 35,000 | 0.00 | — | 39,509 | D | ↗ |
| 2025-07-01 | Arno Andrew | Director | A-Award | A | Common Stock, no par value | 55,000 | 0.00 | — | 136,554 | D | ↗ |
| 2025-03-26 | Riggs Josh | Officer | A-Award | A | Restricted Stock Units | 188,679 | 0.00 | — | 188,679 | D | ↗ |
| 2025-03-26 | Liu James Yang | Officer | A-Award | A | Restricted Stock Units | 18,867 | 0.00 | — | 18,867 | D | ↗ |
| 2025-03-26 | James Andrea S. | Officer | A-Award | A | Restricted Stock Units | 113,207 | 0.00 | — | 113,207 | D | ↗ |
| 2025-02-07 | SMITH PATRICK W | 10% Owner | J-Other | A | Common Stock, no par value | 385,814 | 2.05 | 790.9K | 3,258,485 | I | ↗ |
| 2025-02-07 | James Andrea S. | Officer | P-Purchase | A | Common Stock, no par value | 97,561 | 2.05 | 200.0K | 151,231 | D | ↗ |
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 4,505,488 | 2.05 | 9.24M | 11,410,100 | D | ↗ |
| 2025-02-04 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 25 | 2.02 | 50.50 | 1,795,071 | I | ↗ |
| 2025-01-31 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 890 | 2.01 | 1.8K | 1,795,046 | I | ↗ |
| 2025-01-30 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 318 | 2.01 | 639.18 | 1,794,156 | I | ↗ |
| 2025-01-29 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 3,880 | 2.01 | 7.8K | 1,793,838 | I | ↗ |
| 2025-01-14 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 10,286 | 2.15 | 22.1K | 1,789,958 | I | ↗ |
| 2025-01-13 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 5,669 | 2.08 | 11.8K | 1,779,572 | I | ↗ |
| 2024-12-26 | SMITH PATRICK W | 10% Owner | P-Purchase | A | Common Stock, no par value | 90,219 | 2.13 | 192.2K | 1,773,903 | I | ↗ |
| 2024-12-26 | Arno Andrew | Director | P-Purchase | A | Common Stock, no par value | 12,500 | 2.11 | 26.4K | 81,554 | D | ↗ |
| 2024-12-05 | James Andrea S. | Officer | P-Purchase | A | Common Stock, no par value | 20,000 | 2.29 | 45.8K | 53,670 | D | ↗ |
| 2024-10-11 | James Andrea S. | Officer | A-Award | A | Restricted Stock Units | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2024-10-02 | James Andrea S. | Officer | P-Purchase | A | Common Stock, no par value | 33,670 | 2.97 | 100.0K | 33,670 | D | ↗ |
| 2024-10-02 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,315,339 | 2.95 | 3.88M | 6,244,405 | D | ↗ |
| 2024-07-01 | SILVERMAN LOU | Director | A-Award | A | Option to Purchase Common Stock | 30,000 | 2.95 | 88.5K | 30,000 | — | ↗ |
| 2024-07-01 | Last Andrew J. | Director | A-Award | A | Option to Purchase Common Stock | 30,000 | 2.95 | 88.5K | 30,000 | — | ↗ |
| 2024-07-01 | Arno Andrew | Director | A-Award | A | Option to Purchase Common Stock | 30,000 | 2.95 | 88.5K | 30,000 | — | ↗ |
| 2024-06-20 | James Andrea S. | Officer | A-Award | A | Option to Purchase Common Stock | 200,000 | 2.87 | 574.0K | 200,000 | — | ↗ |
| 2024-06-17 | James Andrea S. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-20 | Riggs Josh | Director / Officer | A-Award | A | Option to Purchase Common Stock | 90,000 | 2.76 | 248.4K | 90,000 | — | ↗ |
| 2024-05-20 | Liu James Yang | Officer | A-Award | A | Option to Purchase Common Stock | 10,000 | 2.76 | 27.6K | 10,000 | — | ↗ |
| 2024-05-20 | Arno Andrew | Director | A-Award | A | Option to Purchase Common Stock | 20,000 | 2.76 | 55.2K | 20,000 | — | ↗ |
| 2024-04-15 | BROADWOOD PARTNERS, L.P. | 10% Owner | J-Other | D | Series A Convertible Preferred Stock | 0 | 30.60 | — | 0 | — | ↗ |
| 2024-04-11 | Riggs Josh | Director / Officer | P-Purchase | A | Common Stock, no par value | 3,390 | 2.95 | 10.0K | 3,505 | — | ↗ |
| 2024-04-11 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,420,000 | 2.92 | 7.06M | 4,929,066 | — | ↗ |
| 2024-04-11 | Arno Andrew | Director | P-Purchase | A | Common Stock, no par value | 33,898 | 2.95 | 100.0K | 69,054 | — | ↗ |
| 2023-12-07 | SILVERMAN LOU | Director | — | D | Option to Purchase Common Stock | 27,987 | 0.46 | 13.0K | — | — | ↗ |
| 2023-12-07 | Riggs Josh | Officer | — | D | Option to Purchase Common Stock | 250,000 | 0.46 | 116.1K | — | — | ↗ |
| 2023-10-10 | Liu James Yang | Officer | A-Award | A | Option to Purchase Common Stock | 8,482 | 3.11 | 26.4K | 8,482 | — | ↗ |
| 2023-08-15 | Riggs Josh | Director / Officer | A-Award | A | Option to Purchase Common Stock | 40,000 | 3.34 | 133.6K | 40,000 | — | ↗ |
| 2023-06-30 | Gutfreund John Peter | — | J-Other | D | Warrants to Purchase Common Stock | 3,564,728 | 1.53 | 5.45M | 0 | — | ↗ |
| 2023-06-23 | SILVERMAN LOU | Director | A-Award | A | Common Stock, no par value | 25,000 | 0.00 | — | 31,270 | — | ↗ |
| 2023-06-23 | Last Andrew J. | Director | A-Award | A | Option to Purchase Common Stock | 90,000 | 0.20 | 18.0K | 90,000 | — | ↗ |
| 2023-06-23 | KINGSLEY ALFRED D | Director | A-Award | A | Option to Purchase Common Stock | 90,000 | 0.20 | 18.0K | 90,000 | — | ↗ |
| 2023-06-23 | Arno Andrew | Director | A-Award | A | Common Stock, no par value | 30,000 | 0.00 | — | 703,133 | — | ↗ |
| 2023-06-14 | KINGSLEY ALFRED D | Director | P-Purchase | A | Common Stock, no par value | 30,000 | 0.21 | 6.4K | 469,111 | — | ↗ |
| 2023-06-09 | Riggs Josh | Director / Officer | A-Award | A | Option to Purchase Common Stock | 800,000 | 0.21 | 170.6K | 800,000 | — | ↗ |
| 2023-04-14 | PURA VIDA INVESTMENTS, LLC | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-05 | PURA VIDA INVESTMENTS, LLC | 10% Owner | P-Purchase | A | Common Stock | 663,000 | 0.30 | 200.0K | 8,090,202 | — | ↗ |
| 2023-04-03 | Gutfreund John Peter | Director | A-Award | A | Common Stock, no par value | 705,000 | 0.35 | 249.9K | 715,000 | — | ↗ |
| 2023-04-03 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 26,827,638 | 0.30 | 8.09M | 50,181,335 | — | ↗ |
| 2023-04-03 | Arno Andrew | Director | A-Award | A | Common Stock, no par value | 141,084 | 0.35 | 50.0K | 156,084 | — | ↗ |
| 2023-03-06 | PURA VIDA INVESTMENTS, LLC | 10% Owner | J-Other | D | Warrant to purchase common stock | 440,964 | 1.53 | 674.7K | 517,245 | — | ↗ |
| 2023-02-24 | Riggs Josh | Officer | A-Award | A | Option to Purchase Common Stock | 116,426 | 0.39 | 45.4K | 116,426 | — | ↗ |
| 2023-02-24 | John Anish M. | Officer | A-Award | A | Option to Purchase Common Stock | 121,381 | 0.39 | 47.3K | 121,381 | — | ↗ |
| 2023-01-17 | Riggs Josh | Officer | A-Award | A | Option to Purchase Common Stock | 257,485 | 0.00 | — | 257,485 | — | ↗ |
| 2023-01-17 | Liu James Yang | Officer | A-Award | A | Option to Purchase Common Stock | 57,065 | 0.00 | — | 57,065 | — | ↗ |
| 2023-01-17 | John Anish M. | Officer | A-Award | A | Option to Purchase Common Stock | 250,466 | 0.00 | — | 250,466 | — | ↗ |
| 2022-12-23 | Gutfreund John Peter | Director | P-Purchase | A | Common Stock, no par value | 75,000 | 0.33 | 24.7K | 75,000 | — | ↗ |
| 2022-12-23 | Arno Andrew | Director | P-Purchase | A | Common Stock, no par value | 250,000 | 0.35 | 87.9K | 532,049 | — | ↗ |
| 2022-12-22 | KINGSLEY ALFRED D | Director | P-Purchase | A | Common Stock, no par value | 25,000 | 0.29 | 7.1K | 439,111 | — | ↗ |
| 2022-12-21 | Ross Douglas T. | Officer | A-Award | A | Common Stock, no par value | 213,797 | 0.00 | — | 234,114 | — | ↗ |
| 2022-12-16 | Ross Douglas T. | Officer | D-Return | D | Option to Purchase Common Stock | 143,438 | 0.00 | — | 111,562 | — | ↗ |
| 2022-12-16 | Paulsen Gisela | Officer | D-Return | D | Option to Purchase Common Stock | 171,875 | 0.00 | — | 203,125 | — | ↗ |
| 2022-12-07 | ANDREWS RONALD ASBURY | Officer | A-Award | A | Option to Purchase Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-12-02 | Riggs Josh | Officer | — | D | Common Stock, no par value | 0 | 0.00 | — | 2,308 | — | ↗ |
| 2022-12-01 | Ross Douglas T. | Officer | D-Return | D | Common Stock, no par value | 150,000 | 0.00 | — | 20,317 | — | ↗ |
| 2022-12-01 | Paulsen Gisela | Officer | D-Return | D | Common Stock, no par value | 175,000 | 0.00 | — | 366,500 | — | ↗ |
| 2022-12-01 | ANDREWS RONALD ASBURY | Officer | M-Exempt | A | Common Stock, no par value | 250,000 | 0.00 | — | 583,212 | — | ↗ |
| 2022-11-30 | SILVERMAN LOU | Director | — | D | Common Stock, no par value | 0 | 0.00 | — | 6,270 | — | ↗ |
| 2022-08-17 | Last Andrew J. | Director | P-Purchase | A | Common Stock, no par value | 20,000 | 0.87 | 17.4K | 70,170 | — | ↗ |
| 2022-08-17 | Arno Andrew | Director | P-Purchase | A | Common Stock, no par value | 7,500 | 0.90 | 6.8K | 15,000 | — | ↗ |
| 2022-08-16 | ANDREWS RONALD ASBURY | Officer | P-Purchase | A | Common Stock, no par value | 40,000 | 0.96 | 38.4K | 333,212 | — | ↗ |
| 2022-08-15 | Ross Douglas T. | Officer | A-Award | A | Common Stock, no par value | 150,000 | 0.00 | — | 170,317 | — | ↗ |
| 2022-08-15 | Paulsen Gisela | Officer | A-Award | A | Common Stock, no par value | 175,000 | 0.00 | — | 191,500 | — | ↗ |
| 2022-08-15 | Last Andrew J. | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2022-08-15 | KINGSLEY ALFRED D | Director | P-Purchase | A | Common Stock, no par value | 5,000 | 0.97 | 4.9K | 409,111 | — | ↗ |
| 2022-08-15 | John Anish M. | Officer | A-Award | A | Option to Purchase Common Stock | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-08-15 | Gutfreund John Peter | Director | A-Award | A | Common Stock, no par value | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-08-15 | GRIFFITH MELINDA | Director | P-Purchase | A | Common Stock, no par value | 10,000 | 1.00 | 10.0K | 30,000 | — | ↗ |
| 2022-08-15 | Carter Jennifer L. | Director | P-Purchase | A | Common Stock, no par value | 10,500 | 0.95 | 10.0K | 30,500 | — | ↗ |
| 2022-08-15 | Arno Andrew | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2022-07-28 | Gutfreund John Peter | Director | — | I | Common Stock, no par value | 0 | 0.00 | — | 3,085,047 | — | ↗ |
| 2022-06-24 | Redmond Cavan M. | Director | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 0 | — | ↗ |
| 2022-06-24 | PURA VIDA INVESTMENTS, LLC | 10% Owner | S-Sale | D | Common Stock | 10,964 | 1.05 | 11.5K | 7,462,643 | — | ↗ |
| 2022-06-24 | Last Andrew J. | Director | M-Exempt | A | Common Stock, no par value | 10,000 | 0.00 | — | 40,170 | — | ↗ |
| 2022-06-24 | Kamen Efrem | Director | S-Sale | D | Common Stock | 12,517 | 1.05 | 13.2K | 8,520,146 | — | ↗ |
| 2022-06-24 | KINGSLEY ALFRED D | Director | M-Exempt | A | Common Stock, no par value | 10,000 | 0.00 | — | 394,111 | — | ↗ |
| 2022-06-24 | GRIFFITH MELINDA | Director | M-Exempt | A | Common Stock, no par value | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-24 | Carter Jennifer L. | Director | M-Exempt | A | Common Stock, no par value | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-06-24 | Arno Andrew | Director | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 0 | — | ↗ |
| 2022-06-01 | John Anish M. | Officer | A-Award | A | Option to Purchase Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-05-18 | Yu Li | Officer | M-Exempt | D | Restricted Stock Units | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-04-14 | PURA VIDA INVESTMENTS, LLC | 10% Owner | P-Purchase | A | Warrant to purchase common stock | 383,976 | 1.53 | 587.5K | 383,976 | — | ↗ |
| 2022-04-14 | Kamen Efrem | Director | P-Purchase | A | Common Stock | 767,952 | 1.33 | 1.02M | 767,952 | — | ↗ |
| 2022-04-14 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 0.00 | — | 23,353,697 | — | ↗ |
| 2022-04-13 | BROADWOOD PARTNERS, L.P. | 10% Owner | A-Award | A | Series A Convertible Preferred Stock | 0 | 1.53 | — | 5,882 | — | ↗ |
| 2022-04-13 | BROADWOOD CAPITAL INC | Director | P-Purchase | A | Common Stock, no par value | 6,003,752 | 1.33 | 8.00M | 23,353,697 | — | ↗ |
| 2022-03-25 | Ross Douglas T. | Officer | P-Purchase | A | Common Stock, no par value | 15,000 | 1.40 | 21.0K | 20,317 | — | ↗ |
| 2022-03-16 | Redmond Cavan M. | Director | P-Purchase | A | Common Stock, no par value | 40,000 | 1.19 | 47.6K | 110,863 | — | ↗ |
| 2022-03-16 | ANDREWS RONALD ASBURY | Director / Officer | P-Purchase | A | Common Stock, no par value | 50,000 | 1.28 | 64.2K | 293,212 | — | ↗ |
| 2022-03-15 | Yu Li | Officer | A-Award | A | Option to Purchase Common Stock | 37,500 | 0.00 | — | 37,500 | — | ↗ |
| 2022-03-15 | Sundar Padmavathi | Officer | A-Award | A | Option to Purchase Common Stock | 87,500 | 0.00 | — | 87,500 | — | ↗ |
| 2022-03-15 | Ross Douglas T. | Officer | A-Award | A | Option to Purchase Common Stock | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-03-15 | Paulsen Gisela | Officer | P-Purchase | A | Common Stock, no par value | 16,500 | 1.20 | 19.8K | 16,500 | — | ↗ |
| 2022-03-15 | Levine Mitchell S | Officer | A-Award | A | Option to Purchase Common Stock | 87,500 | 0.00 | — | 87,500 | — | ↗ |
| 2022-03-15 | ANDREWS RONALD ASBURY | Director / Officer | A-Award | A | Option to Purchase Common Stock | 375,000 | 1.15 | 431.3K | 375,000 | — | ↗ |
| 2021-10-04 | Paulsen Gisela | Officer | — | D | Option to Purchase Common Stock | 375,000 | 3.42 | 1.28M | 0 | — | ↗ |
| 2021-09-23 | BROADWOOD PARTNERS, L.P. | 10% Owner | X-InTheMoney | A | Common Stock, no par value | 573,461 | 3.15 | 1.81M | 17,349,945 | — | ↗ |
| 2021-08-24 | Carter Jennifer L. | Director | — | D | Option to Purchase Common Stock | 57,000 | 1.40 | 79.8K | 0 | — | ↗ |
| 2021-07-01 | ANDREWS RONALD ASBURY | Director / Officer | F-InKind | D | Common Stock, no par value | 15,834 | 0.00 | — | 243,212 | — | ↗ |
| 2021-06-30 | ANDREWS RONALD ASBURY | Director / Officer | F-InKind | D | Common Stock, no par value | 25,873 | 0.00 | — | 194,046 | — | ↗ |
| 2021-06-24 | Yu Li | Officer | A-Award | A | Option to Purchase Common Stock | 160,000 | 4.33 | 692.8K | 160,000 | — | ↗ |
| 2021-06-24 | Redmond Cavan M. | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 5.46 | 245.7K | 45,000 | — | ↗ |
| 2021-06-24 | Last Andrew J. | Director | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-06-24 | KINGSLEY ALFRED D | Director | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-06-24 | GRIFFITH MELINDA | Director | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-06-24 | Carter Jennifer L. | Director | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-06-24 | Arno Andrew | Director | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2021-06-11 | Last Andrew J. | Director | X-InTheMoney | A | Common Stock | 6,993 | 3.00 | 21.0K | 30,170 | — | ↗ |
| 2021-05-18 | Yu Li | Officer | — | D | Restricted Stock Units | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2021-05-07 | ANDREWS RONALD ASBURY | Director / Officer | M-Exempt | D | Restricted Stock Units | 106,221 | 0.00 | — | 0 | — | ↗ |
| 2021-04-28 | Levine Mitchell S | Officer | M-Exempt | D | Restricted Stock Units | 20,000 | 0.00 | — | 0 | — | ↗ |
| 2021-03-19 | ANDREWS RONALD ASBURY | Director / Officer | P-Purchase | A | Common Stock, no par value | 11,000 | 4.79 | 52.7K | 113,698 | — | ↗ |
| 2021-02-25 | Sundar Padmavathi | Officer | A-Award | A | Employee Stock Option (right to buy) | 255,000 | 5.34 | 1.36M | 255,000 | — | ↗ |
| 2021-02-25 | Ross Douglas T. | Officer | A-Award | A | Employee Stock Option (right to buy) | 255,000 | 5.34 | 1.36M | 255,000 | — | ↗ |
| 2021-02-25 | Levine Mitchell S | Officer | A-Award | A | Employee Stock Option (right to buy) | 255,000 | 5.34 | 1.36M | 255,000 | — | ↗ |
| 2021-02-25 | ANDREWS RONALD ASBURY | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 500,000 | 5.34 | 2.67M | 500,000 | — | ↗ |
| 2021-02-05 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 0.00 | — | 16,776,484 | — | ↗ |
| 2021-01-20 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 0.00 | — | 16,176,484 | — | ↗ |
| 2020-12-28 | KINGSLEY ALFRED D | Director | M-Exempt | A | Option to purchase common stock | 65,271 | 1.34 | 87.5K | 0 | — | ↗ |
| 2020-12-23 | KINGSLEY ALFRED D | Director | M-Exempt | A | Option to purchase common stock | 1,237 | 1.34 | 1.7K | 65,271 | — | ↗ |
| 2020-12-22 | KINGSLEY ALFRED D | Director | M-Exempt | A | Common Stock, no par value | 10,516 | 1.34 | 14.1K | 326,155 | — | ↗ |
| 2020-12-21 | KINGSLEY ALFRED D | Director | M-Exempt | A | Common Stock, no par value | 47,976 | 1.34 | 64.3K | 350,787 | — | ↗ |
| 2020-12-11 | Sundar Padmavathi | Officer | A-Award | A | Common Stock | 4,177 | 2.07 | 8.6K | 4,177 | — | ↗ |
| 2020-12-11 | Ross Douglas T. | Officer | A-Award | A | Common Stock | 5,317 | 2.07 | 11.0K | 5,317 | — | ↗ |
| 2020-12-11 | Redmond Cavan M. | Director | A-Award | A | Common Stock | 18,416 | 2.07 | 38.1K | 70,863 | — | ↗ |
| 2020-12-11 | Parker Albert P | Officer | A-Award | A | Common Stock | 5,586 | 2.07 | 11.6K | 10,586 | — | ↗ |
| 2020-12-11 | Levine Mitchell S | Officer | A-Award | A | Common Stock | 10,121 | 2.07 | 21.0K | 46,700 | — | ↗ |
| 2020-12-11 | Last Andrew J. | Director | A-Award | A | Common Stock | 16,184 | 2.07 | 33.5K | 23,177 | — | ↗ |
| 2020-12-11 | KINGSLEY ALFRED D | Director | A-Award | A | Common Stock | 5,909 | 2.07 | 12.2K | 302,811 | — | ↗ |
| 2020-12-11 | HESTERBERG LYNDAL K. | Officer | A-Award | A | Common Stock | 6,603 | 2.07 | 13.7K | 7,477 | — | ↗ |
| 2020-12-11 | Arno Andrew | Director | A-Award | A | Common Stock | 9,602 | 2.07 | 19.9K | 112,049 | — | ↗ |
| 2020-09-12 | Levine Mitchell S | Officer | P-Purchase | A | Common Stock | 10,000 | 2.01 | 20.1K | 13,495 | — | ↗ |
| 2020-08-03 | Parker Albert P | Officer | P-Purchase | A | Common Stock, no par value | 5,000 | 1.33 | 6.6K | 5,000 | — | ↗ |
| 2020-08-03 | Levine Mitchell S | Officer | P-Purchase | A | Common Stock, no par value | 10,000 | 1.32 | 13.2K | 36,579 | — | ↗ |
| 2020-08-03 | KALAJIAN TONY T | Officer | P-Purchase | A | Common Stock, no par value | 5,000 | 1.31 | 6.5K | 15,000 | — | ↗ |
| 2020-08-03 | ANDREWS RONALD ASBURY | Director / Officer | P-Purchase | A | Common Stock, no par value | 40,000 | 1.35 | 53.9K | 102,698 | — | ↗ |
| 2020-06-17 | Redmond Cavan M. | Director | A-Award | A | Option to purchase common stock | 62,000 | 2.38 | 147.6K | 62,000 | — | ↗ |
| 2020-06-17 | Last Andrew J. | Director | A-Award | A | Option to purchase common stock | 57,000 | 2.38 | 135.7K | 57,000 | — | ↗ |
| 2020-06-17 | KINGSLEY ALFRED D | Director | A-Award | A | Option to purchase common stock | 57,000 | 2.38 | 135.7K | 57,000 | — | ↗ |
| 2020-06-17 | GRIFFITH MELINDA | Director | A-Award | A | Option to purchase common stock | 57,000 | 2.38 | 135.7K | 57,000 | — | ↗ |
| 2020-06-17 | Arno Andrew | Director | A-Award | A | Option to purchase common stock | 57,000 | 2.38 | 135.7K | 57,000 | — | ↗ |
| 2020-05-07 | ANDREWS RONALD ASBURY | Director / Officer | A-Award | A | Restricted Stock Units | 106,221 | 0.00 | — | 106,221 | — | ↗ |
| 2020-04-28 | Levine Mitchell S | Officer | A-Award | A | Restricted Stock Units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2020-04-24 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,050,000 | 2.27 | 2.38M | 14,716,204 | — | ↗ |
| 2020-03-31 | ANDREWS RONALD ASBURY | Director / Officer | P-Purchase | A | Common Stock, no par value | 18,000 | 2,372.00 | 42.70M | 62,698 | — | ↗ |
| 2020-03-30 | ANDREWS RONALD ASBURY | Officer | P-Purchase | A | Common Stock, no par value | 27,216 | 2.26 | 61.5K | 44,698 | — | ↗ |
| 2020-03-23 | Ross Douglas T. | Officer | — | D | Option to Purchase Common Stock | 250,000 | 1.93 | 482.5K | 0 | — | ↗ |
| 2020-03-14 | Levine Mitchell S | Officer | M-Exempt | D | Restricted Stock Units | 20,000 | 0.00 | — | 0 | — | ↗ |
| 2020-02-10 | Sundar Padma | Officer | A-Award | A | Option to purchase common stock | 255,000 | 2.63 | 670.7K | 255,000 | — | ↗ |
| 2020-02-10 | Parker Albert P | Officer | A-Award | A | Option to purchase common stock | 204,000 | 2.63 | 536.5K | 204,000 | — | ↗ |
| 2020-02-10 | Levine Mitchell S | Officer | A-Award | A | Option to purchase common stock | 204,000 | 2.63 | 536.5K | 204,000 | — | ↗ |
| 2020-02-10 | KALAJIAN TONY T | Officer | A-Award | A | Option to purchase common stock | 204,000 | 2.63 | 536.5K | 204,000 | — | ↗ |
| 2020-01-20 | PURA VIDA INVESTMENTS, LLC | 10% Owner | — | I | Common Stock, No Par Value | 0 | 0.00 | — | 12,223,953 | — | ↗ |
| 2020-01-02 | Lineage Cell Therapeutics, Inc. | — | S-Sale | D | Common Stock, no par value | 2,383,090 | 2.16 | 5.14M | 6,041,154 | — | ↗ |
| 2020-01-02 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 0.00 | — | 13,666,204 | — | ↗ |
| 2019-11-13 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,176,471 | 1.70 | 2.00M | 12,274,738 | — | ↗ |
| 2019-09-17 | Arno Andrew | Director | P-Purchase | A | Common Stock, no par value | 50,000 | 2.16 | 108.1K | 102,447 | — | ↗ |
| 2019-09-13 | KALAJIAN TONY T | Officer | P-Purchase | A | Common Stock, no par value | 10,000 | 1.98 | 19.8K | 10,000 | — | ↗ |
| 2019-09-12 | Levine Mitchell S | Officer | P-Purchase | A | Common Stock | 10,000 | 2.01 | 20.1K | 13,495 | — | ↗ |
| 2019-09-11 | Lineage Cell Therapeutics, Inc. | 10% Owner | S-Sale | D | Common Stock, no par value | 4,000,000 | 1.66 | 6.64M | 8,424,244 | — | ↗ |
| 2019-09-11 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,000,000 | 1.66 | 3.32M | 11,098,267 | — | ↗ |
| 2019-08-09 | KALAJIAN TONY T | Officer | — | D | Option to Purchase Common Stock | 275,000 | 1.94 | 533.5K | 0 | — | ↗ |
| 2019-07-17 | Redmond Cavan M. | Director | A-Award | A | Option to Purchase Common Stock | 50,000 | 2.12 | 106.0K | 50,000 | — | ↗ |
| 2019-07-17 | MOHANTY ADITYA P. | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 2.12 | 95.4K | 45,000 | — | ↗ |
| 2019-07-17 | Last Andrew J. | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 2.12 | 95.4K | 45,000 | — | ↗ |
| 2019-07-17 | KINGSLEY ALFRED D | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 2.12 | 95.4K | 45,000 | — | ↗ |
| 2019-07-17 | GRIFFITH MELINDA | Director | — | D | Option to Purchase Common Stock | 45,000 | 2.12 | 95.4K | 0 | — | ↗ |
| 2019-07-17 | Arno Andrew | Director | A-Award | A | Option to Purchase Common Stock | 45,000 | 2.12 | 95.4K | 45,000 | — | ↗ |
| 2019-07-05 | BIOTIME INC | 10% Owner | S-Sale | D | Common Stock, no par value | 2,250,000 | 2.00 | 4.50M | 12,424,244 | — | ↗ |
| 2019-07-02 | BROADWOOD PARTNERS, L.P. | 10% Owner | P-Purchase | A | Common Stock, no par value | 0 | 2.00 | — | 9,098,267 | — | ↗ |
| 2019-07-01 | ANDREWS RONALD ASBURY | Director / Officer | A-Award | A | Option to Purchase Common Stock | 950,000 | 2.51 | 2.38M | 950,000 | — | ↗ |
| 2019-05-22 | Sundar Padma | Officer | — | D | Option to Purchase Common Stock | 180,000 | 4.94 | 889.2K | 0 | — | ↗ |
| 2019-03-14 | Parker Albert P | Officer | A-Award | A | Option to Purchase Common Stock | 200,000 | 3.52 | 704.0K | 200,000 | — | ↗ |
| 2019-03-14 | Levine Mitchell S | Officer | A-Award | A | Option to Purchase Common Stock | 245,000 | 3.52 | 862.4K | 245,000 | — | ↗ |
| 2019-03-14 | HESTERBERG LYNDAL K. | Officer | A-Award | A | Option to Purchase Common Stock | 350,000 | 3.52 | 1.23M | 350,000 | — | ↗ |
| 2019-03-14 | ANNETT WILLIAM | Director / Officer | A-Award | A | Option to Purchase Common Stock | 390,000 | 3.52 | 1.37M | 390,000 | — | ↗ |
| 2019-02-15 | MOHANTY ADITYA P. | Director | A-Award | A | Option to Purchase Common Stock | 33,750 | 3.80 | 128.3K | 33,750 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-6.6K
Shares Outstanding
26.84M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Joshua Riggs President and Chief Executive Officer | 385.0K | 166.4K | — | 209.7K | — | 25.0K | 786.1K | 26.68% | ↗ |
| 2 | 2024 | Andrea James Chief Financial Officer | 175.2K | 72.8K | 173.0K | 330.0K | — | 7.9K | 758.9K | 66.28% | ↗ |
| 3 | 2024 | Ekkehard Schütz Chief Science Officer | 370.4K | 166.8K | — | 81.6K | — | 14.9K | 633.6K | 12.87% | ↗ |
| 4 | 2024 | James Liu Senior Director, Controller and Principal Accounting Officer | 204.5K | 63.9K | — | 23.3K | — | 12.3K | 303.9K | 7.67% | ↗ |
| 5 | 2023 | Joshua Riggs President and Chief Executive Officer | 339.8K | 117.0K | — | 220.3K | — | 47.8K | 724.9K | 30.39% | ↗ |
| 6 | 2023 | Ekkehard Schütz Chief Science Officer | 242.0K | 132.7K | — | 165.9K | — | 34.5K | 575.2K | 28.84% | ↗ |
| 7 | 2023 | Anish John Former Chief Financial Officer | 147.1K | — | — | 97.2K | — | 204.8K | 449.2K | 21.64% | ↗ |
| 8 | 2023 | James Liu Senior Director, Controller and Principal Accounting Officer | 191.4K | 52.9K | — | 44.7K | — | 15.6K | 304.5K | 14.67% | ↗ |
| 9 | 2023 | James Liu Controller and Principal Accounting Officer | 191.4K | 52.9K | — | 44.7K | — | 15.6K | 304.5K | 14.67% | ↗ |
| 10 | 2022 | Ronald Andrews Former President and Chief Executive Officer | 459.7K | — | 493.1K | 745.9K | — | 653.8K | 2.35M | 52.67% | ↗ |
| 11 | 2022 | Gisela Paulsen Former President and Chief Operating Officer | 356.4K | — | 509.3K | 233.7K | — | 241.7K | 1.34M | 55.40% | ↗ |
| 12 | 2022 | Douglas Ross Former Chief Science Officer | 359.1K | — | 201.8K | 187.0K | — | 400.8K | 1.15M | 33.84% | ↗ |
| 13 | 2022 | Anish John Former Chief Financial Officer | 286.0K | 98.8K | 145.5K | 189.6K | — | 18.3K | 738.2K | 45.40% | ↗ |
| 14 | 2022 | Anish John Chief Financial Officer | 286.0K | 98.8K | 145.5K | 189.6K | — | 18.3K | 738.2K | 45.40% | ↗ |
| 15 | 2022 | Joshua Riggs President and Chief Executive Officer | 242.0K | 94.8K | — | 140.9K | — | 36.4K | 514.1K | 27.41% | ↗ |
| 16 | 2022 | James Liu Controller and Principal Accounting Officer | 146.3K | 36.3K | — | 67.3K | — | 9.8K | 259.7K | 25.89% | ↗ |
| 17 | 2021 | Ronald Andrews President and Chief Executive Officer | 480.0K | 297.6K | — | 2.12M | — | 24.2K | 2.92M | 72.56% | ↗ |
| 18 | 2021 | Ronald Andrews Former President and Chief Executive Officer | 480.0K | 297.6K | — | 2.12M | — | 24.2K | 2.92M | 72.56% | ↗ |
| 19 | 2021 | Douglas Ross Former Chief Science Officer | 375.0K | 165.8K | — | 1.08M | — | 18.2K | 1.64M | 65.92% | ↗ |
| 20 | 2021 | Douglas Ross Chief Science Officer | 375.0K | 165.8K | — | 1.08M | — | 18.2K | 1.64M | 65.92% | ↗ |
| 21 | 2021 | Mitchell Levine Chief Financial Officer | 356.9K | 110.6K | — | 1.08M | — | 13.2K | 1.56M | 69.22% | ↗ |
| 22 | 2020 | Albert P. Parker Chief Operating Officer | 348.9K | 133.5K | — | 530.4K | — | 386.1K | 1.40M | 37.88% | ↗ |
| 23 | 2020 | Mitchell Levine Chief Financial Officer | 362.0K | 131.7K | 44.8K | 504.4K | — | 14.8K | 1.06M | 51.89% | ↗ |
| 24 | 2020 | Ronald Andrews President and Chief Executive Officer | 487.4K | 465.6K | — | 68.5K | — | 16.2K | 1.05M | 6.54% | ↗ |
| 25 | 2020 | Douglas Ross Chief Science Officer | 375.0K | — | — | 386.5K | — | 11.2K | 980.4K | 39.42% | ↗ |
| 26 | 2020 | Padma Sundar Senior Vice President, Marketing and Market Access | 293.3K | 60.0K | — | 543.2K | — | 11.7K | 908.4K | 59.79% | ↗ |
| 27 | 2019 | Ronald Andrews President and Chief Executive Officer | 276.3K | — | 163.2K | 1.63M | — | — | 2.07M | 86.63% | ↗ |
| 28 | 2019 | William Annett Former President and Chief Executive Officer | 275.8K | 73.5K | — | 955.5K | — | 324.0K | 1.63M | 58.66% | ↗ |
| 29 | 2019 | Lyndal K. Hesterberg Chief Scientific Officer | 298.4K | 60.0K | — | 857.1K | — | 1.3K | 1.22M | 70.44% | ↗ |
| 30 | 2019 | Mitchell Levine Chief Financial Officer | 343.1K | 131.7K | 70.4K | 600.1K | — | 12.7K | 1.16M | 57.91% | ↗ |
| 31 | 2019 | Albert P. Parker Chief Operating Officer | 350.2K | 57.1K | — | 490.0K | — | 14.0K | 911.4K | 53.77% | ↗ |
| 32 | 2019 | Padma Sundar Senior Vice President, Marketing and Market Access | 158.3K | — | — | 615.6K | — | — | 773.9K | 79.54% | ↗ |
| 33 | 2018 | William Annett Former President and Chief Executive Officer | 400.0K | 220.0K | — | 292.1K | — | 13.8K | 925.8K | 31.55% | ↗ |
| 34 | 2018 | William Annett President and Chief Executive Officer | 400.0K | 220.0K | — | 292.1K | — | 13.8K | 925.8K | 31.55% | ↗ |
| 35 | 2018 | Mitchell Levine Chief Financial Officer | 330.0K | 200.0K | — | 359.3K | — | — | 889.3K | 40.40% | ↗ |
| 36 | 2018 | Lyndal K. Hesterberg Chief Scientific Officer | 216.7K | 311.8K | — | 314.9K | — | 7.1K | 850.6K | 37.03% | ↗ |
| 37 | 2017 | William Annett President and Chief Executive Officer | 397.3K | 40.0K | — | 740.3K | — | 13.5K | 1.19M | 62.15% | ↗ |
| 38 | 2017 | Mitchell Levine Chief Financial Officer | 41.9K | 8.7K | — | 579.0K | — | — | 629.6K | 91.97% | ↗ |
| 39 | 2017 | Kristine C. Mechem VP of Marketing | 225.6K | 27.1K | — | 222.1K | — | 13.5K | 488.3K | 45.48% | ↗ |
| 40 | 2017 | Lyndal K. Hesterberg Chief Scientific Officer | 210.8K | 33.7K | — | 47.4K | — | 7.5K | 299.4K | 15.83% | ↗ |
| 41 | 2017 | Lyndal K. Hesterberg Senior VP of Research and Development | 210.8K | 33.7K | — | 47.4K | — | 7.5K | 299.4K | 15.83% | ↗ |
| 42 | 2016 | William Annett President and Chief Executive Officer | 380.0K | 171.0K | — | 481.5K | — | 12.1K | 1.04M | 46.09% | ↗ |
| 43 | 2016 | Lyndal K. Hesterberg Senior VP of Research and Development | 35.1K | 12.6K | — | 414.9K | — | 208.8K | 671.5K | 61.79% | ↗ |
| 44 | 2016 | Karen B. Chapman VP of Research | 230.0K | 69.0K | — | 115.6K | — | 9.9K | 424.5K | 27.22% | ↗ |
| 45 | 2016 | Kristine C. Mechem VP of Marketing | 210.0K | 66.2K | — | 115.6K | — | 11.8K | 403.5K | 28.64% | ↗ |
| 46 | 2016 | Russell L. Skibsted Chief Financial Officer | 67.7K | — | — | — | — | 2.3K | 70.0K | 0.00% | ↗ |
| 47 | 2015 | William Annett President and Chief Executive Officer | 173.3K | 93.3K | — | 852.2K | — | 21.3K | 1.14M | 74.75% | ↗ |
| 48 | 2015 | Karen Chapman VP of Research | 186.7K | 55.0K | — | 145.4K | — | 8.6K | 395.8K | 36.74% | ↗ |
| 49 | 2015 | Karen B. Chapman VP of Research | 186.7K | 55.0K | — | 145.4K | — | 8.6K | 395.8K | 36.74% | ↗ |
| 50 | 2015 | Alfred D. Kingsley Former Executive Chairman | 79.2K | 100.0K | — | 197.3K | — | 4.0K | 380.5K | 51.87% | ↗ |
| 51 | 2015 | Kristine Mechem VP of Marketing | 83.3K | 25.0K | — | 201.6K | — | 3.3K | 313.3K | 64.36% | ↗ |
| 52 | 2015 | Kristine C. Mechem VP of Marketing | 83.3K | 25.0K | — | 201.6K | — | 3.3K | 313.3K | 64.36% | ↗ |
| 53 | 2015 | Robert W. Peabody Former Chief Financial Officer | 57.5K | 6.8K | — | 197.4K | — | 34.5K | 296.0K | 66.67% | ↗ |
| 54 | 2015 | Joseph P. Wagner Former President and Chief Executive Officer | 147.4K | — | — | 112.7K | — | 6.3K | 266.4K | 42.31% | ↗ |
| 55 | 2015 | Lyndal K. Hesterberg Senior VP of Research and Development | — | — | — | — | — | 51.4K | 51.4K | 0.00% | ↗ |
| 56 | 2015 | Russell L. Skibsted Chief Financial Officer | 6.8K | — | — | — | — | 225.00 | 7.0K | 0.00% | ↗ |
| 57 | 2014 | Joseph P. Wagner Former President and Chief Executive Officer | 267.8K | 75.0K | — | — | — | 12.6K | 355.4K | 0.00% | ↗ |
| 58 | 2014 | Karen Chapman VP of Research | 149.6K | 25.0K | — | — | — | 6.7K | 181.3K | 0.00% | ↗ |
| 59 | 2014 | Karen B. Chapman VP of Research | 149.6K | 25.0K | — | — | — | 6.7K | 181.3K | 0.00% | ↗ |
| 60 | 2014 | Alfred D. Kingsley Former Executive Chairman | 100.0K | — | — | — | — | 4.3K | 104.3K | 0.00% | ↗ |
| 61 | 2014 | Robert W. Peabody Former Chief Financial Officer | 40.0K | 13.5K | — | — | — | 1.2K | 54.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joshua Riggs | President, Chief Executive Officer & Director | 662.8K | male |
| Ekkehard Schutz | Chief Science Officer | 552.0K | — |
| Andrea Susan James | Chief Financial Officer | 536.6K | female |
| James Liu | Vice President of Accounting, Treasurer, Controller & Principal Accounting Officer | 303.3K | male |
| Peter Hong | Vice President, General Counsel & Secretary | — | male |
| Sandra O'Donald | Senior Vice President of Business Operations | — | female |
| Steven Tahmooressi | Vice President of Marketing | — | male |
| Yuh-Min Chiang | Chief Technology Officer | — | male |
| Gabrielle Woody | Sr. Executive Assistant | — | female |
| Michael D. West | Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. | — | — |
| Paul R. Billings FACP | Consulting Chief Medical Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMDX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
